CIC/ATXN1 ‐rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series
Brain Pathology · 2025
DOI: 10.1111/bpa.13303 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Brain Pathology, 2025. Verfasst von Arnault Tauziède-Espariat und 33 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France. Hauptthemen laut MEDLINE: Repressor Proteins, Central Nervous System Neoplasms, Sarcoma, Ataxin-1. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
CIC fusions have been described in two different central nervous system (CNS) tumor entities. On one hand, fusions of CIC or ATXN1 genes belonging to the same complex of transcriptional repressors, were reported in the CIC‐ rearranged, sarcoma (SARC ‐CIC ). The diagnosis of this tumor type, which was recently added to the World Health Organization (WHO) Classification of CNS tumors, is difficult mainly because the data concerning its histopathology (as compared to its soft tissue counterpart), immunoprofile, and clinical as well as radiological characteristics are scarce in the literature. On the other hand, a recent study, based on DNA‐methylation profiling, has identified a novel high‐grade neuroepithelial tumor characterized by recurrent CIC fusions (HGNET‐ CIC ). The aim of this multicentric study was to characterize a cohort of 15 primary CNS tumors harboring a CIC or ATXN1 fusion in terms of clinical, radiological, histopathological, immunophenotypical, and epigenetic characteristics. According to the integrated diagnoses, 14/15 tumors corresponded to SARC ‐CIC, and only one to HGNET‐ CIC . The tumors showed similar clinical (mainly pediatric), radiological (mostly supratentorial, cystic, and contrast enhancing), immunophenotypical (common expression of glioneuronal markers), and genetic (similar spectrum of fusions) profiles but their histopathological appearance was clearly distinct. Moreover, we found a novel fusion transcript ( CIC::EWSR1 ) in a SARC‐ CIC. Most DNA methylation profiles using the Heidelberg Brain Tumor Classifier (v12.8) annotated the samples to the methylation class “SARC‐ CIC ” (9/14 tumors with available data). By using uniform manifold approximation and projection analysis, four other samples were classified as SARC‐ CIC and another clustered within the methylation class of HGNET‐ CIC . Our findings confirm that CNS CIC ‐fused tumors do not represent a single molecular tumor entity. Further analyses are needed to characterize HGNET‐ CIC in more detail. These results may help to refine the essential diagnostic criteria for SARC‐ CIC and their terminology (with a suggested consensual name of sarcoma, CIC/ATXN1‐ complex rearranged).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropathology, GHU Paris-Psychiatrie et Neurosciences, Sainte-Anne Hospital, Paris, France.
- INSERM U1266, IMABrain, Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, Paris, France.
- Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn, Bonn, Germany.
- Pediatric Radiology Department, Hôpital Necker Enfants Malades, AP-HP, Paris, France.
- UMR 1163, Institut Imagine and INSERM U1299, Université Paris Cité, Paris, France.
- Department of Pathology, The Children's Memorial Health Institute, Warsaw, Poland.
ORCID-Profile: Arnault Tauziède-Espariat, Emmanuelle Uro-Coste, Franck Bielle
Zitieren
APA
Tauziède-Espariat, A., Ebrahimi, A., Boddaert, N., Pietsch, T., Grajkowska, W., Blau, T., Koch, A., Sievers, P., Guillemot, D., Pierron, G., Uro-Coste, E., Nicaise, Y., Siegfried, A., Gilles, A., Bielle, F., Mokhtari, K., Cazals-Hatem, D., Iakovlev, G., Lhermitte, B., …, & RENOCLIP‐LOC (2025). CIC/ATXN1 ‐rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series. Brain Pathology. https://doi.org/10.1111/bpa.13303
Vancouver
Tauziède-Espariat A, Ebrahimi A, Boddaert N, Pietsch T, Grajkowska W, Blau T, et al. CIC/ATXN1 ‐rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series. Brain Pathology. 2025. doi:10.1111/bpa.13303
BibTeX
@article{TauzideEspariat2025,
author = {Tauziède-Espariat, Arnault and Ebrahimi, Azadeh and Boddaert, Nathalie and Pietsch, Torsten and Grajkowska, Wieslawa and Blau, Tobias and Koch, Arend and Sievers, Philipp and Guillemot, Delphine and Pierron, Gaëlle and Uro-Coste, Emmanuelle and Nicaise, Yvan and Siegfried, Aurore and Gilles, Adam and Bielle, Franck and Mokhtari, Karima and Cazals-Hatem, Dominique and Iakovlev, Gueorgui and Lhermitte, Benoît and Entz-Werle, Natacha and Csanyi, Marie and Maurage, Claude-Alain and Legrand, Victor and Boutonnat, Jean and Godfraind, Catherine and McLeer, Anne and Hasty, Lauren and Métais, Alice and Aboubakr, Oumaima and Blauwblomme, Thomas and Beccaria, Kévin and Dangouloff-Ros, Volodia and Varlet, Pascale and RENOCLIP‐LOC, RENOCLIP‐LOC},
title = {CIC/ATXN1 ‐rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series},
journal = {Brain Pathology},
year = {2025},
doi = {10.1111/bpa.13303}
}
EUVIMED